巨细胞Mtdh缺乏不和地调节瘤生长和转移,通过增加的血栓蛋白-1生产
Yu Jiang1, Lingyuan Min2, Xinyu Yang2
1Department of Clinical Research Center, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Journal for immunotherapy of cancer
|February 24, 2026
概括
巨甲素 (MTDH) 缺乏通过抗血管生成阻碍瘤转移,但矛盾的是,通过TSP-1/TGF-β1通路增加纤维化促进瘤生长. 这揭示了癌症进展中的双重作用.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 甲素 (MTDH) 是一种瘤基因,与癌症的进展和转移有关.
- 在瘤进展过程中,巨细胞中MTDH的表达需要进一步研究其生物学作用.
研究的目的:
- 阐明巨甲素 (MTDH) 在调节瘤转移和生长中的双重作用.
- 研究MTDH对瘤进展的不和影响背后的分子机制.
主要方法:
- 使用髓状腺特异性麻小鼠进行皮下和静脉瘤注射.
- 使用质谱学,免疫光学,TCGA数据和西部涂抹检查了血管新生和纤维化的影响.
- 通过RNA测序,ELISA,免疫沉,ChIP,qPCR和西部涂抹来研究分子机制.
主要成果:
- 缺乏Mtdh的巨细胞抑制了肺转移,但促进了皮下瘤的生长.
- 这与增加的血栓蛋白-1 (TSP-1) 生产有关,通过转化生长因子β1 (TGF-β1) 激活抑制血管生成和促进纤维化.
- 巨细胞中的MTDH损失通过TSP-1/TGF-β1轴促进纤维化和瘤生长,涉及MDM2和p53.
结论:
- 巨细胞Mtdh的缺乏表现出瘤转移和生长的调节不一致.
- 该研究强调了一种新的TSP-1/TGF-β1轴机制驱动这种不一致.
- 提供了关于瘤生长和转移之间的复杂相互作用的新见解.
相关概念视频
mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K
The Tumor Microenvironment
8.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
Abnormal Proliferation
5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Regulation of Angiogenesis and Blood Supply
3.8K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.8K
Metastasis
6.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K


